GSK-843
GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 8.6 nM, and inhibits kinase activity with an IC50 of 6.5 nM. GSK-843 can be used for the research of inflammation[1][2].
Product Specifications
CAS Number
1601496-05-2
Product Name Alternative
GSK'843
UNSPSC
12352005
Target
Apoptosis; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gsk-843.html
Purity
99.18
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
NC1=NC=C(C2=CC(C)=NN2C)C3=C1C(C4=CC=C(SC=N5)C5=C4)=CS3
Molecular Formula
C19H15N5S2
Molecular Weight
377.49
References & Citations
[1]Mandal P, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014 Nov 20;56 (4) :481-95.|[2]Kaiser WJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013 Oct 25;288 (43) :31268-79.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN424081 1 Kit
Malignant fibrous histiocytoma (MFHAS1) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
LC419249 20 µg
Occludin (OCLN) (NM_002538) Human Over-expression Lysate
Sign In for Pricing
View Details 
